NO952781L - Potensiering av temozolomid i humane tumorceller - Google Patents

Potensiering av temozolomid i humane tumorceller

Info

Publication number
NO952781L
NO952781L NO952781A NO952781A NO952781L NO 952781 L NO952781 L NO 952781L NO 952781 A NO952781 A NO 952781A NO 952781 A NO952781 A NO 952781A NO 952781 L NO952781 L NO 952781L
Authority
NO
Norway
Prior art keywords
temozolomide
potentialization
tumor cells
human tumor
atase
Prior art date
Application number
NO952781A
Other languages
English (en)
Norwegian (no)
Other versions
NO952781D0 (no
Inventor
John Colin Baer
Azadeh Alison Freeman
Edward Stuart Newlands
Amanda Jean Watson
Joseph Anthony Rafferty
Geoffrey Paul Margison
Original Assignee
Cancer Res Campaign Tech
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cancer Res Campaign Tech filed Critical Cancer Res Campaign Tech
Publication of NO952781D0 publication Critical patent/NO952781D0/no
Publication of NO952781L publication Critical patent/NO952781L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO952781A 1993-01-14 1995-07-13 Potensiering av temozolomid i humane tumorceller NO952781L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US475493A 1993-01-14 1993-01-14
PCT/GB1994/000065 WO1994015615A1 (en) 1993-01-14 1994-01-13 Potentiation of temozolomide in human tumour cells

Publications (2)

Publication Number Publication Date
NO952781D0 NO952781D0 (no) 1995-07-13
NO952781L true NO952781L (no) 1995-09-13

Family

ID=21712364

Family Applications (1)

Application Number Title Priority Date Filing Date
NO952781A NO952781L (no) 1993-01-14 1995-07-13 Potensiering av temozolomid i humane tumorceller

Country Status (20)

Country Link
EP (2) EP0679086A1 (cs)
JP (1) JPH08505615A (cs)
KR (1) KR100352046B1 (cs)
CN (1) CN1277541C (cs)
AU (1) AU5838494A (cs)
CA (1) CA2153775C (cs)
CZ (1) CZ286550B6 (cs)
FI (1) FI953423L (cs)
HU (1) HUT72665A (cs)
IL (1) IL108328A (cs)
MX (1) MX9400434A (cs)
MY (1) MY116474A (cs)
NO (1) NO952781L (cs)
PL (1) PL175842B1 (cs)
RU (1) RU2148401C1 (cs)
SK (1) SK282452B6 (cs)
TW (1) TW414710B (cs)
UA (1) UA29466C2 (cs)
WO (1) WO1994015615A1 (cs)
ZA (1) ZA94248B (cs)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5731304A (en) * 1982-08-23 1998-03-24 Cancer Research Campaign Technology Potentiation of temozolomide in human tumour cells
US5942247A (en) * 1996-07-31 1999-08-24 Schering Corporation Method for treating pediatric high grade astrocytoma including brain stem glioma
US5939098A (en) * 1996-09-19 1999-08-17 Schering Corporation Cancer treatment with temozolomide
US6251886B1 (en) 1998-12-07 2001-06-26 Schering Corporation Methods of using temozolomide in the treatment of cancers
WO2000033823A2 (en) * 1998-12-07 2000-06-15 Schering Corporation Methods of using temozolomide in the treatment of cancers
US6465448B1 (en) * 1999-08-13 2002-10-15 Case Western Reserve University Methoxyamine potentiation of temozolomide anti-cancer activity
US6635677B2 (en) 1999-08-13 2003-10-21 Case Western Reserve University Methoxyamine combinations in the treatment of cancer
DE60321450D1 (de) * 2002-02-22 2008-07-17 Schering Corp Pharmazeutische zubereitungen von antineoplastischen wirkstoffen, insbesondere temozolomid, verfahren zu ihrer herstellung und deren verwendung
EP2431385A3 (en) * 2002-05-31 2012-07-04 Morphotek, Inc. Combination therapy with chlorotoxin
CN100366249C (zh) * 2002-09-29 2008-02-06 天津帝士力投资控股集团有限公司 一种替莫唑胺控释给药系统
CN1752088A (zh) * 2004-09-22 2006-03-29 天津市金士力药物研究开发有限公司 含有替莫唑胺酯的药用组合物
CN100402091C (zh) * 2005-02-03 2008-07-16 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100350974C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 一种抗癌药物组合物
CN100350975C (zh) * 2005-02-03 2007-11-28 山东蓝金生物工程有限公司 抗癌药物组合物
CN100431605C (zh) * 2005-02-03 2008-11-12 山东蓝金生物工程有限公司 一种抗癌药物组合物
GB0502573D0 (en) * 2005-02-08 2005-03-16 Topotarget As Therapeutic compounds
RU2318509C2 (ru) * 2006-02-10 2008-03-10 Всеволод Иванович Киселев Твердая лекарственная форма дииндолилметана для лечения неопластических заболеваний
WO2008022535A1 (fr) * 2006-08-09 2008-02-28 Tian Jin Tasly Group Co., Ltd. Composition pharmaceutique pour traiter le gliome du cerveau, son procédé et sa préparation pharmaceutique
AU2009246142A1 (en) 2008-05-15 2009-11-19 Transmolecular, Inc. Treatment of metastatic tumors
CA2788824C (en) 2010-02-04 2019-03-12 Morphotek, Inc. Chlorotoxin polypeptides and conjugates and uses thereof
AU2011253424B2 (en) 2010-05-11 2016-02-04 Fred Hutchinson Cancer Center Chlorotoxin variants, conjugates, and methods for their use
CN103169664B (zh) * 2011-12-25 2015-04-22 复旦大学 一种rgd肽修饰的双层载药纳米粒及其制备方法
CA2913127A1 (en) 2012-12-10 2014-06-19 Fred Hutchinson Cancer Research Center Methods for screening
US11559580B1 (en) 2013-09-17 2023-01-24 Blaze Bioscience, Inc. Tissue-homing peptide conjugates and methods of use thereof
CA3021011A1 (en) 2016-04-15 2017-10-19 Blaze Bioscience, Inc. Methods of treating breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352669A (en) * 1990-03-13 1994-10-04 The Of The United States Of America As Represented By The Department Of Health And Human Services O6 -benzylated guanine, guanosine and 2'-deoxyguanosine compounds possessing O6 -alkylguanine-DNA alkyltransferase depleting activity

Also Published As

Publication number Publication date
UA29466C2 (uk) 2000-11-15
EP0922458A1 (en) 1999-06-16
MY116474A (en) 2004-02-28
CN1277541C (zh) 2006-10-04
HUT72665A (en) 1996-05-28
WO1994015615A1 (en) 1994-07-21
KR960700063A (ko) 1996-01-19
MX9400434A (es) 1994-07-29
SK89295A3 (en) 1996-06-05
IL108328A (en) 2010-05-31
EP0679086A1 (en) 1995-11-02
ZA94248B (en) 1994-07-13
CZ179795A3 (en) 1996-04-17
CZ286550B6 (cs) 2000-05-17
AU5838494A (en) 1994-08-15
CA2153775A1 (en) 1994-07-21
HU9502117D0 (en) 1995-09-28
JPH08505615A (ja) 1996-06-18
KR100352046B1 (ko) 2003-09-03
CA2153775C (en) 2000-11-14
CN1117711A (zh) 1996-02-28
PL175842B1 (pl) 1999-02-26
RU2148401C1 (ru) 2000-05-10
FI953423A7 (fi) 1995-08-23
FI953423L (fi) 1995-08-23
PL309915A1 (en) 1995-11-13
FI953423A0 (fi) 1995-07-13
IL108328A0 (en) 1994-04-12
SK282452B6 (sk) 2002-02-05
NO952781D0 (no) 1995-07-13
TW414710B (en) 2000-12-11

Similar Documents

Publication Publication Date Title
NO952781L (no) Potensiering av temozolomid i humane tumorceller
EA200001245A1 (ru) КОМПОЗИЦИИ НА ОСНОВЕ ПИРРОЛО [2,3d] ПИРИМИДИНОВ И ИХ ПРИМЕНЕНИЕ
ATE203751T1 (de) K-252a derivate, die neurotrophin-induzierte aktivität erhöhen
PT1140944E (pt) Derivados de epotilona e sua utilizacao como agentes antitumorais
BG98902A (bg) Имидазолови производни и тяхната употреба като инхибитори на цитокин
EA200200097A1 (ru) Имидазоимидазолы и триазолы в качестве противовоспалительных агентов
PT907652E (pt) Compostos e processos imunossupressores
TR199800012T1 (xx) Piroloprimidinler ve preparasyon i�in tatbikler.
ES2089687T3 (es) 4-fenil-piridonas y 4-fenil-2-alcoxipiridinas sustituidas como inhibidores de la hmg-coa-reductasa.
DK0556310T3 (da) Quinazolinderivater til forhøjelse af antitumoraktivitet
ATE240334T1 (de) Pyrrolobenzodiazepine
ES2174863T3 (es) Compuestos de pirimidina y su uso como compuestos farmaceuticos.
ES2071484T3 (es) Derivados de 2,4-diaminoquinazolinas para aumentar la actividad antitumoral.
ATE387450T1 (de) Meso-substituierte porphyrine
BR0108715A (pt) Compostos de 3,4-diidro-1h-pirimido[4,5-d]-pirimidin-2-ona 1,5-dissubstituìdos e seu uso no tratamento de doenças mediadas pela cinase csbp/p38
RU94042393A (ru) Галихондрины, родственные соединения и способ лечения опухоли у млекопитающих
AR009560A1 (es) Prolongacion de la sobrevida de injertos con porfirinas
EA200200808A1 (ru) Модифицированные цитокины, предназначенные для применения в терапии рака
IT1264530B (it) Impiego dei polisaccaridi nelle neuropatie atrofico degenerative
DK0869965T3 (da) Steroidnitritesterderivater anvendelige som antiinflammatoriske lægemidler
DE60115466D1 (de) Wirkstoffvorläufer von imidazopyridin-derivaten
PT983272E (pt) Nova classe de compostos fotoactivos derivados de benzoporfirina
BR0115121A (pt) Compostos n-((1,2,4)triazoloazinil)tiofenossulfonamida como herbicidas
NO890046D0 (no) Disubstituerte pyridiner.
DE69126469D1 (de) Pyrimidin-Nukleosid-Derivate und antivirale Mittel, die diese Derivate als aktiven Bestandteil enthalten

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application